MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

Protect from moisture and light.

Provenance

This compatibility recommendation is derived from Famvir 125mg tablets (Phoenix Labs Ltd).

Stability Notes

Protect from moisture and light.

Provenance

This compatibility recommendation is derived from Famvir 250mg tablets (Phoenix Labs Ltd).

Stability Notes

Protect from moisture and light.

Provenance

This compatibility recommendation is derived from Famvir 250mg tablets (Phoenix Labs Ltd).

Stability Notes

Protect from moisture and light.

Provenance

This compatibility recommendation is derived from Famvir 500mg tablets (Phoenix Labs Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Flomaxtra XL 400microgram tablets (Astellas Pharma Ltd).

Stability Notes

Protect from light.

Provenance

This compatibility recommendation is derived from Fareston 60mg tablets (Orion Pharma (UK) Ltd).

Stability Notes

Store in an airtight container and protect from light.

Provenance

This compatibility recommendation is derived from Fluvoxamine 100mg tablets (Wockhardt UK Ltd).

Stability Notes

Store in an airtight container and protect from light.

Provenance

This compatibility recommendation is derived from Fluvoxamine 100mg tablets (Wockhardt UK Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Adenuric 120mg tablets (A. Menarini Farmaceutica Internazionale SRL).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Adenuric 120mg tablets (A. Menarini Farmaceutica Internazionale SRL).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Adenuric 120mg tablets (A. Menarini Farmaceutica Internazionale SRL).

Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Medicines under this category are not suitable for use inside MCAs.
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.